{
  "meta": {
    "title": "Hypertensive_Disorder_In_Pregnancy_And_Rh_Isoimmunisation",
    "url": "https://brainandscalpel.vercel.app/hypertensive-disorder-in-pregnancy-and-rh-isoimmunisation-bcb46314.html",
    "scrapedAt": "2025-11-30T08:49:42.850Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">60</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">80</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">100</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">125</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27 year old primigravida came to ER throwing convulsions. Her BP was 180/110 mmHg. She was started on anticonvulsants & IV antihypertensives. Her fluid intake should be restricted to <___ mL/hr:--</span></p>",
      "unique_key": "DT1289482",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>In women with severe pre-eclampsia, <strong>limit maintenance fluids to 80 ml/hour</strong> unless there are other ongoing fluid losses (for example, haemorrhage).</li>\r\n<li>If fluid administration is not curtailed, it can lead to <strong>pulmonary edema</strong>, which is a life-threatening complication.</li>\r\n<li>In severe preeclampsia or eclampsia, there is a risk of fluid overload due to <strong>impaired renal function</strong> and <strong>the presence of endothelial dysfunction</strong>, which leads to <strong>increased vascular permeability</strong> and a shift of fluids into the interstitial space (<strong>THIRD SPACING</strong>).</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY- Due to risk of pulmonary edema, a life-threatening complication. strict fluid management is crucial to prevent further complications.</strong></p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">1800 mg/day</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">2000 mg/day</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">2200 mg/day</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">2400 mg/day</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24 year old primigravida is diagnosed with preeclampsia at 30 weeks of gestation. The obstetrician prescribes the first line oral drug of choice for preeclampsia to this woman. What is the maximum daily dose of the drug prescribed?</span></p>",
      "unique_key": "DT1289484",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>The first line oral drug of choice for preeclampsia is LABETALOL</strong>.</li>\r\n<li>Labetalol is <strong>an alpha- and beta-receptor blocker</strong> and is safe to use during pregnancy.</li>\r\n<li>Labetalol causes a controlled decrease in blood pressure by <strong>reducing the systemic vascular resistance</strong> in patients with severe hypertension.</li>\r\n<li><strong>The maximum labetalol dosage is 2,400 mg daily</strong>, divided in two or three doses. But dosages this high are typically reserved for people with extremely high blood pressure.</li>\r\n<li>Usual dosages are between 200 mg to 800 mg per day, divided into two doses.</li>\r\n</ul>\r\n<p><strong>KEY</strong> <strong>TAKEAWAY</strong>- <strong>The </strong><strong>maximum labetalol dosage is 2,400 mg daily, divided in two or three doses</strong></p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">120/80 mmHg</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">130/80 mmHg</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">135/85 mmHg</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">140/85 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to NICE guidelines, when using antihypertensives in pregnancy, one should aim for a target blood pressure of:</span></p>",
      "unique_key": "DT1289485",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289485,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>When using medicines to treat hypertension in pregnancy, aim for a target blood pressure of <strong>135/85 mmHg</strong>.</li>\r\n<li>This target aims to strike a balance between reducing the risk of maternal complications from hypertension while avoiding overly aggressive lowering of blood pressure, which could potentially compromise placental perfusion and fetal health.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY-</strong> NICE guidelines regarding blood pressure management in pregnancy:</p>\r\n<ul>\r\n<li><strong>Target BP:</strong> <strong>135/85 mmHg is recommended for women</strong> with chronic hypertension or pregnancy-induced hypertension to minimize the risks of stroke, eclampsia, and other complications, while ensuring sufficient placental blood flow.</li>\r\n<li><strong>Antihypertensives:</strong> Commonly used antihypertensive drugs in pregnancy include <strong>labetalol, nifedipine, and methyldopa.</strong></li>\r\n</ul>\r\n<p><strong>Reference:</strong> NICE guidelines on Hypertension in Pregnancy</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">It is the most frequent of the hypertensive disorders of pregnancy</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">The condition is more frequent in obese women with multiple gestations, diabetes and a previous history of preeclampsia</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternal and perinatal morbidity is not increased in women with gestational hypertension</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Approximately 15-25% of women with gestational hypertension subsequently progress to develop the clinical syndrome of preeclampsia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements hold true for gestational hypertension, except:</span></p>",
      "unique_key": "DT1289487",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289487,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Maternal and perinatal morbidity is not increased in women with gestational hypertension</strong>. This statement is <strong>incorrect</strong> because gestational hypertension is associated with increased maternal and perinatal risks, including progression to <strong>preeclampsia, preterm delivery, placental abruption, and fetal growth restriction.</strong></p>\r\n<p>Optionwise explanations:</p>\r\n<p><strong>a. It is the most frequent of the hypertensive disorders of pregnancy</strong>:<br /> True. Gestational hypertension is one of the most common hypertensive disorders in pregnancy, occurring after 20 weeks of gestation.</p>\r\n<p><strong>b. The condition is more frequent in obese women with multiple gestations, diabetes, and a previous history of preeclampsia</strong>:<br /> True. Women with these risk factors have a higher likelihood of developing gestational hypertension.</p>\r\n<p><strong>d. Approximately 15-25% of women with gestational hypertension subsequently progress to develop the clinical syndrome of preeclampsia</strong>:</p>\r\n<p><strong>KEY TAKEAWAY- Gestational hypertension is associated with increased maternal and perinatal risks, including progression to preeclampsia, preterm delivery, placental abruption, and fetal growth restriction.</strong></p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal artery stenosis</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26 year old primigravida presents at 16 weeks of gestation with paroxysmal hypertension, hypertensive crisis, seizures or panic attacks, palpitations and headaches. Urinary vanillyl mandelic acid and 24-hour metanephrine levels were found to be high. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289488",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Pheochromocytoma is characterized by <strong>paroxysmal hypertension</strong>, <strong>hypertensive crises</strong>, <strong>seizures</strong>, <strong>palpitations</strong>, and <strong>headaches</strong>. The diagnosis is confirmed by elevated <strong>urinary VMA and 24-hour metanephrine</strong> levels, which are key in this case.</p>\r\n<p>Optionwise explanations:</p>\r\n<p><strong>a) Coarctation of aorta</strong></p>\r\n<ul>\r\n<li>Coarctation of the aorta typically presents with <strong>hypertension</strong> (especially in the upper limbs) and may have <strong>differential blood pressure readings between the arms and legs</strong>. It does not usually cause the paroxysmal symptoms (sudden episodes) of hypertension, palpitations, seizures, or elevated urinary VMA and metanephrine levels.</li>\r\n</ul>\r\n<p><strong>b) Renal artery stenosis</strong></p>\r\n<ul>\r\n<li>Renal artery stenosis can cause <strong>hypertension</strong>, particularly resistant hypertension, <strong>but it usually presents with gradual onset rather than paroxysmal symptoms</strong>. It is not associated with elevated catecholamine metabolites like VMA and metanephrines.</li>\r\n</ul>\r\n<p><strong>d) Cushing's syndrome</strong></p>\r\n<ul>\r\n<li>Cushing's syndrome can cause <strong>hypertension</strong>, <strong>weight gain, and other systemic symptoms, but it is not associated with paroxysmal episodes of hypertension</strong>, nor with elevated catecholamine metabolites like VMA and metanephrines</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY -</strong></p>\r\n<p><strong>Pheochromocytoma should be suspected in young women with paroxysmal hypertension, frequent hypertensive crisis, seizures or panic attacks, palpitations and headaches</strong>.</p>\r\n<ul>\r\n<li>They should undergo determination of <strong>plasma metanephrines, urinary vanillylmandelic acid and metanephrines in a 24-urine collection.</strong></li>\r\n<li>If biochemical results are suggestive of pheochromocytoma, <strong>then MRI or CT after the first trimester may be useful for localization of the tumour</strong> which is commonly present in the adrenal gland.</li>\r\n<li>If disease is diagnosed pre-pregnancy or early to mid-pregnancy, it can be treated surgically or pharmacologically with good obstetric outcome.</li>\r\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased capillary permeability</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased renal artery resistance</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Glomerular filtration rate</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased systemic vascular resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the underlying aetiology for proteinuria that is seen with Pre-eclampsia?</span></p>",
      "unique_key": "DT1289492",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289492,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>In pre-eclampsia, endothelial dysfunction leads to increased capillary permeability, especially in the glomeruli of the kidneys. This results in leakage of proteins like albumin into the urine, leading to proteinuria, which is a hallmark of pre-eclampsia.</li>\r\n</ul>\r\n<p>Optionwise explanations:</p>\r\n<p><strong>b) Increased renal artery resistance</strong></p>\r\n<ul>\r\n<li>While there is an increase in vascular resistance in pre-eclampsia, particularly in the uteroplacental circulation, this does not directly explain the proteinuria. Increased renal artery resistance is more likely to cause reduced renal perfusion and oliguria, not proteinuria.</li>\r\n</ul>\r\n<p><strong>c) Increased glomerular filtration rate (GFR)</strong></p>\r\n<ul>\r\n<li>In fact, the GFR tends to be reduced in pre-eclampsia due to compromised renal function. Increased GFR would typically result in increased urine output but is not responsible for proteinuria.</li>\r\n</ul>\r\n<p><strong>d) Increased systemic vascular resistance</strong></p>\r\n<ul>\r\n<li>Pre-eclampsia is characterized by increased systemic vascular resistance (due to vasoconstriction), which contributes to hypertension. However, this does not explain the proteinuria seen in pre-eclampsia.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY- PROTEINURIA IN PREECLAMPSIA </strong></p>\r\n<ul>\r\n<li><strong>Spasm of the afferent glomerular arterioles &rarr; anoxic change to the endothelium of the glomerular tuft &rarr; glomerular endotheliosis &rarr; increased capillary permeability &rarr; increased leakage of proteins.</strong></li>\r\n<li>Tubular reabsorption is simultaneously depressed.</li>\r\n<li>Albumin constitutes 50-60% and alpha globulin constitutes 10-15% of the total proteins excreted in the urine.</li>\r\n</ul>\r\n<p>Diagram showing glomerular endotheliosis</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412068a0726ff-216d-4e1f-b4e7-e8ecb78a112d.jpg\">",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Smoking</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Nulliparity</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple gestation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All except which of the following increase a woman's predisposition to develop preeclampsia?</span></p>",
      "unique_key": "DT1289496",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Interestingly, smoking has been shown to have a paradoxical protective effect against preeclampsia, though it is harmful for many other pregnancy outcomes.</strong></p>\r\n<ul>\r\n<li>First of all, smoking during pregnancy has been associated with lower circulating concentrations of the anti-angiogenic proteins -<strong> sFlt1 and serum endoglin</strong> and higher concentrations of the pro-angiogenic protein - <strong>placental growth factor</strong></li>\r\n<li>Since preeclampsia usually begins after the middle of the second trimester of pregnancy coincident with substantial rises in circulating sFlt1 and sEng, it is not entirely surprising why <strong>smoking during the latter half of pregnancy has a protective effect on preeclampsia</strong>.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011895091b46-5f00-40ca-b185-cca293450d0d.jpg\">\r\n<p>Optionwise explanations:</p>\r\n<p><strong>a) Obesity</strong></p>\r\n<ul>\r\n<li>Obesity is a well-known risk factor for preeclampsia due to the associated metabolic and inflammatory changes that increase the risk of endothelial dysfunction.</li>\r\n</ul>\r\n<p><strong>c) Nulliparity</strong></p>\r\n<ul>\r\n<li>Nulliparity (being pregnant for the first time) is a risk factor for preeclampsia, as the risk is higher in first pregnancies.</li>\r\n</ul>\r\n<p><strong>d) Multiple gestation</strong></p>\r\n<ul>\r\n<li>Multiple gestation (twins or more) increases the risk of preeclampsia due to the larger placental mass and increased vascular demand.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY- RISK FACTORS OF PREECLAMPSIA.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206ad1d25f7-0343-45d2-884f-2f95cde4daa8.jpg\">\r\n<p><strong>Reference: </strong>Karumanchi SA, Levine RJ. How does smoking reduce the risk of preeclampsia? Hypertension. 2010 May;55(5):1100-1.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">DIC</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Fatty Liver of Pregnancy</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">HELLP syndrome</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic Uremic syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26 year old primigravida presents to ER at 34 weeks of gestation with a BP of 180/110 mmHg. She is a known case of preeclampsia on oral labetalol. No complaints of pain in abdomen or bleeding/leaking per vaginum. Routine investigations were sent.<br>CBC showed Hb 9.6 gm/dL, TLC 13.000/cumm, platelet count 65000/cumm.<br>Peripheral smear revealed schistocytes.<br>LFT -  ALT 300 IU/L, AST 250 IU/L, LDH 850 IU/L.<br>RFT - Urea 34 mg/Dl, Serum creatinine 1.1 mg/dL.<br>What is your diagnosis in this case?</span></p>",
      "unique_key": "DT1289499",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289499,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>HELLP syndrome is a life-threatening pregnancy complication characterized by the triad of <strong>H</strong>emolysis<strong>, E</strong>levated <strong>L</strong>iver enzymes<strong>, </strong>and<strong> L</strong>ow<strong> P</strong>latelet count.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120605f43d08-1763-4dd1-83bf-9828a7f19d21.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120643854fb8-8a29-4c6b-8eec-d5e2277fc14c.jpg\">\r\n<p>Optionwise explanations:</p>\r\n<p><strong>a) DIC (Disseminated Intravascular Coagulation)</strong></p>\r\n<ul>\r\n<li>DIC involves widespread clotting and bleeding due to the consumption of clotting factors. It can present with low platelets and schistocytes, but the characteristic elevated liver enzymes and the LDH in this case suggest HELLP syndrome rather than DIC as the primary diagnosis.</li>\r\n</ul>\r\n<p><strong>b) Acute Fatty Liver of Pregnancy</strong></p>\r\n<ul>\r\n<li>Acute Fatty Liver of Pregnancy (AFLP) presents with elevated liver enzymes and can cause liver failure, but it is usually associated with more <strong>severe liver dysfunction, elevated ammonia, and encephalopathy, which are not present</strong> Additionally, the platelet count is typically not as low as in HELLP syndrome.</li>\r\n</ul>\r\n<p><strong>d) Hemolytic Uremic Syndrome (HUS)</strong></p>\r\n<ul>\r\n<li>HUS involves <strong>hemolysis, renal impairment, and thrombocytopeni</strong>a, but is more commonly associated with severe renal dysfunction (e.g., elevated serum creatinine, oliguria), which is not prominent in this case. The liver involvement in this patient suggests HELLP syndrome rather than HUS.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY-</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206816fc463-b7ea-404b-9a4f-9d6f3a31cf1a.jpg\">",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output, Respiratory rate, Deep Tendon reflexes</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">PT INR, SpO2 & urine output</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">ECG, LFT & coagulation profile</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory rate, SpO2 & ECG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26 year old primigravida is brought to ER at 34 weeks gestation with convulsions. She was unconscious. Her BP was recorded to be 210/120 mmHg, Pulse 88 bpm, RR 14 breaths/min. After primary management, MgSO4 is administered for seizure control. Which of the following parameters are used for monitoring MgSO4 therapy?</span></p>",
      "unique_key": "DT1289501",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Correct</strong> monitoring parameters for magnesium therapy include:\r\n<ul>\r\n<li><strong>Urine output</strong>: To assess kidney function and avoid magnesium toxicity, as magnesium is excreted through the kidneys. Reduced urine output increases the risk of magnesium accumulation.</li>\r\n<li><strong>Respiratory rate</strong>: Magnesium sulfate can cause respiratory depression, so monitoring respiratory rate is essential.</li>\r\n<li><strong>Deep tendon reflexes (DTRs)</strong>: Magnesium toxicity can lead to loss of DTRs, so regular assessment helps monitor for early signs of toxicity.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>b) PT INR, SpO2 &amp; urine output</strong></p>\r\n<ul>\r\n<li>While <strong>SpO2</strong> and <strong>urine output</strong> are useful in clinical monitoring, <strong>PT INR</strong> (prothrombin time) is not typically relevant to magnesium sulfate monitoring. PT INR is more related to coagulation status.</li>\r\n</ul>\r\n<p><strong>c) ECG, LFT &amp; coagulation profile</strong></p>\r\n<ul>\r\n<li><strong>ECG</strong> can be used if there are concerns about cardiac function, but it's not a primary parameter for magnesium monitoring. <strong>LFT</strong> and <strong>coagulation profile</strong> are more related to liver function and coagulation status, not magnesium toxicity.</li>\r\n</ul>\r\n<p><strong>d) Respiratory rate, SpO2 &amp; ECG</strong></p>\r\n<ul>\r\n<li>While <strong>respiratory rate</strong> and <strong>SpO2</strong> are important, <strong>ECG</strong> is not routinely used to monitor magnesium therapy unless there are cardiac concerns. Deep tendon reflexes and urine output are better indicators of magnesium toxicity.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY:</strong> Monitoring for magnesium toxicity:</p>\r\n<ul>\r\n<li>Urine output should be at least 30 mL/hour</li>\r\n<li>Deep tendon reflexes should be present</li>\r\n<li>Respiration rate should be at least 14 breaths/minute</li>\r\n<li>Pulse oximetry (SpO2) should be &gt; 96%</li>\r\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Supplementation of which of the following elements in the antenatal period is associated with decreased incidence of preeclampsia?</span></p>",
      "unique_key": "DT1289504",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Calcium supplementation</strong> during pregnancy, particularly in women with low dietary calcium intake, has been shown to reduce the risk of developing preeclampsia. Calcium is believed to improve vascular smooth muscle function and reduce blood pressure.</p>\r\n<ul>\r\n<li><strong>Calcium may prevent preeclampsia</strong> by decreasing the release of parathormone and consequently the intracellular calcium concentration resulting in decreased smooth muscle contractility.</li>\r\n<li>The decrease in risk was greater in women at high risk for developing hypertension and in women with a diet deficient in calcium.</li>\r\n<li>Dosage of calcium supplementation in women with low calcium intake is <strong>5-2 g /day</strong> for preeclampsia prevention.</li>\r\n</ul>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Iron</strong></p>\r\n<ul>\r\n<li>Iron supplementation is crucial for preventing maternal anemia during pregnancy, but there is no significant evidence linking iron supplementation to a reduction in the incidence of preeclampsia.</li>\r\n</ul>\r\n<p><strong>c) Magnesium</strong></p>\r\n<ul>\r\n<li>Magnesium supplementation can be used for <strong>seizure prophylaxis</strong> in women with preeclampsia, but routine antenatal magnesium supplementation has not been associated with a significant reduction in preeclampsia incidence.</li>\r\n</ul>\r\n<p><strong>d) Selenium</strong></p>\r\n<ul>\r\n<li>Selenium is important for antioxidant defense, and deficiency has been linked to complications in pregnancy. However, its role in specifically reducing preeclampsia is not well established.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY- some methods to prevent preeclampsia</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412066f938ad4-5ad7-44e9-b378-46fe4e944820.jpg\">",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous nephropathy</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranoproliferative nephropathy</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomerular endotheliosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrosclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify this hallmark renal lesion seen in cases of preeclampsia:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412063b09caba-997d-41e0-9c42-8f4c4a9d59a4.jpg\"></span></p>",
      "unique_key": "DT1289507",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289507,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Glomerular endotheliosis</strong> is the characteristic renal lesion of preeclampsia. It is marked by swelling and damage to the endothelial cells of the glomeruli, leading to proteinuria. This is the hallmark lesion of preeclampsia.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412063e610692-7f98-42ce-8b7f-9c430bdd48a3.jpg\">\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Membranous nephropathy</strong></p>\r\n<ul>\r\n<li>This is a common cause of nephrotic syndrome, characterized by thickened glomerular basement membranes. It is not typically associated with preeclampsia.</li>\r\n</ul>\r\n<p><strong>b) Membranoproliferative nephropathy</strong></p>\r\n<ul>\r\n<li>This condition involves both membrane thickening and cell proliferation in the glomeruli. It is not a hallmark lesion of preeclampsia.</li>\r\n</ul>\r\n<p><strong>d) Nephrosclerosis</strong></p>\r\n<ul>\r\n<li>Nephrosclerosis refers to hardening of the small blood vessels in the kidneys, typically due to chronic hypertension. While hypertension is involved in preeclampsia, nephrosclerosis is not the hallmark lesion.</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY</strong> -<strong>In preeclampsia, the changes are conspicuous in the glomerulus which becomes enlarged (glomerular endotheliosis).</strong></p>\r\n<ul>\r\n<li>Endothelial cells swell up and fibrin-like deposits occur in the basement membrane. The lumen may be occluded. Interstitial cells in between the capillaries proliferate.</li>\r\n<li>There is associated spasm of the afferent glomerular arterioles. Patchy areas of damage of the tubular epithelium due to anoxia are evident.</li>\r\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle Cerebral Artery Doppler</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">SFlt 1 levels</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean Arterial BP</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll over test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following tests can be used for prediction of preeclampsia, except:</span></p>",
      "unique_key": "DT1289510",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Middle Cerebral Artery (MCA) Doppler</strong> is typically used to assess fetal well-being, especially in cases of fetal anemia or growth restriction. It is <strong>not</strong> used for predicting preeclampsia.</p>\r\n<p><strong>Uterine artery is used for preeclampsia</strong>.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>b) SFlt-1 levels</strong></p>\r\n<ul>\r\n<li><strong>sFlt-1 (soluble fms-like tyrosine kinase-1)</strong> is an antiangiogenic factor that is elevated in preeclampsia. A high sFlt-1/PlGF (placental growth factor) ratio can be used to predict the risk of preeclampsia.</li>\r\n</ul>\r\n<p><strong>c) Mean Arterial BP</strong></p>\r\n<ul>\r\n<li><strong>Mean Arterial Pressure (MAP)</strong> is a predictor of preeclampsia. Elevated MAP in early pregnancy has been associated with an increased risk of developing the condition.</li>\r\n</ul>\r\n<p><strong>d) Roll over test</strong></p>\r\n<ul>\r\n<li>The <strong>roll-over test</strong> assesses a woman's blood pressure response when turning from a supine to lateral position. An exaggerated increase in blood pressure during this test has been historically used as a predictor of preeclampsia, though it is less commonly used now.</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY- </strong>Screening tests for prediction and prevention of PREECLAMPSIA: More than 100 clinical, biophysical and biochemical tests have been tried to predict the onset of the disease.</p>\r\n<ul>\r\n<li><strong>Doppler ultrasound of high resistance index in the uterine artery</strong>,second trimester is associated with sixfold increase in rate of preeclampsia. Presence of diastolic notch at 24 weeks' gestation in the uterine artery can predict the possible development of preeclampsia.</li>\r\n<li>Development of renal dysfunction: <strong>Rise in the level of serum uric acid</strong> and appearance of microalbuminuria are observed to be the predictors of preeclampsia.</li>\r\n<li><strong>Absence of end-diastolic frequencies or reverse diastolic flow patterns in the umbilical artery</strong> usually indicates poor perinatal outcome.</li>\r\n<li><strong>Average mean arterial pressure (MAP) in second trimester &gt; 90 mm </strong>Hg may predict the onset.</li>\r\n<li><strong>Maternal serum level of SFlt-1 is increased</strong> in women with preeclampsia.</li>\r\n<li>Fetal DNA-<strong>Detection of free fetal DNA (ff DNA) in maternal plasma</strong> in early pregnancy may be predictive of preeclampsia.</li>\r\n<li><strong>Roll over test: </strong>This screening test is done between 28 and 32 weeks. Blood pressure is measured with the patient on her side first and then the patient is asked to roll on her back to check the blood pressure once again. An increase of 20 mm Hg in diastolic pressure from side to back position indicates a positive 'roll over test'. About 33% of women with positive 'roll over test' developed hypertension later.</li>\r\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Number of seizure episodes more than ten</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Coma in between seizures</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature over 102&deg;F</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulse > 100 bpm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22 year old primigravida suffered from eclampsia at 32 weeks gestation. All of the following suggest a poor prognosis, except:</span></p>",
      "unique_key": "DT1289513",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289513,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>A pulse rate over 100 bpm (tachycardia) in a patient with eclampsia can occur due to pain, anxiety, or other stressors</strong>, but <strong>is not necessarily a marker of poor prognosis</strong> on its own unless associated with other signs of cardiovascular instability.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Number of fits more than ten</strong></p>\r\n<ul>\r\n<li>Multiple seizures (especially more than 10) indicate severe neurological involvement and are associated with a <strong>poor prognosis</strong> due to increased risk of cerebral edema, hemorrhage, and hypoxia.</li>\r\n</ul>\r\n<p><strong>b) Coma in between fits</strong></p>\r\n<ul>\r\n<li>Coma between seizures suggests significant brain injury and is a marker of <strong>poor prognosis</strong> in eclampsia.</li>\r\n</ul>\r\n<p><strong>c) Temperature over 102&deg;F</strong></p>\r\n<ul>\r\n<li>Elevated body temperature (hyperthermia) in eclampsia can be a sign of severe systemic inflammation or infection and is typically associated with a <strong>poor prognosis</strong>.</li>\r\n</ul>\r\n<p><strong>d) Pulse &gt; 100 bpm</strong></p>\r\n<ul>\r\n<li>A pulse rate over 100 bpm (tachycardia) in a patient with eclampsia can occur due to pain, anxiety, or other stressors, but <strong>is not necessarily a marker of poor prognosis</strong> on its own unless associated with other signs of cardiovascular instability.</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY</strong> -</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412060338b4b6-37ce-4050-96ad-521a88b3380b.jpg\">",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Methyldopa</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitroglycerine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antihypertensive drugs may lead to postnatal depression?</span></p>",
      "unique_key": "DT1289515",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289515,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Methyldopa</strong> is an alpha-2 agonist often used in managing hypertension in pregnancy. One of its known side effects is <strong>postnatal depression</strong>, which has been documented in some cases.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Labetalol</strong></p>\r\n<ul>\r\n<li>Labetalol is a commonly used beta-blocker for hypertension in pregnancy. It is not typically associated with postnatal depression.</li>\r\n</ul>\r\n<p><strong>b) Nifedipine</strong></p>\r\n<ul>\r\n<li>Nifedipine, a calcium channel blocker, is also used in pregnancy for hypertension management but has no strong link to postnatal depression.</li>\r\n</ul>\r\n<p><strong>c) Methyldopa</strong></p>\r\n<ul>\r\n<li><strong>Methyldopa</strong> is an alpha-2 agonist often used in managing hypertension in pregnancy. One of its known side effects is <strong>postnatal depression</strong>, which has been documented in some cases.</li>\r\n</ul>\r\n<p><strong>d) Nitroglycerine</strong></p>\r\n<ul>\r\n<li>Nitroglycerine is a vasodilator used in acute hypertensive emergencies but is not associated with postnatal depression.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY - Methyldopa has been the most widely used antihypertensive drug during pregnancy for decades but lately is being replaced by labetalol as the first choice drug. </strong></p>\r\n<ul>\r\n<li><strong>The site of action of the medication is the central nervous system.</strong> The effect of methyldopa is mainly on reducing systemic vascular resistance with little effect on the heart rate and cardiac output.</li>\r\n<li><strong>The most common side effect of methyldopa is postural hypotension</strong>, which subsides rather quickly with a decrease in the amount of medication.</li>\r\n<li><strong>It should be avoided in women with a prior history of depression, because of increased risk of postnatal depression.</strong></li>\r\n</ul>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin & Caesarean delivery</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">MgS04 & expectant management</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">MgS04 & Induction of labour</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">MgS04 & Caesarean delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38 year old primigravida at 28 weeks of gestation following in vitro fertilization presents to the ER via ambulance with an ongoing generalized tonic-clonic seizure that started 20 minutes ago. Her blood pressure is 180/110 mm Hg, and her heart rate is 95 bpm. She is not in labour, cervix is unripe. Fetal bradycardia is noticed on CTG.  What is the most appropriate management?</span></p>",
      "unique_key": "DT1289517",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289517,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>This patient presents with eclampsia.</p>\r\n<ul>\r\n<li><strong>Magnesium sulfate and Caesarean delivery are preferred in this scenario</strong> <strong>due to gestational age &amp; non-reassuring fetal status.</strong></li>\r\n<li><strong>Magnesium sulfate is first-line treatment for eclampsia</strong> because it prevents the recurrence and decreases the risk of maternal mortality. It is more effective than phenytoin in reducing recurrent seizures in patients with eclampsia.</li>\r\n<li>Eclampsia is an absolute contraindication to expectant management; however, it is not an absolute contraindication to vaginal delivery.</li>\r\n<li>Here the cervix is unripe, IOL would be a tedious procedure which may prove detrimental to maternal health.</li>\r\n<li>Also, <strong>fetal bradycardia necessitates emergent delivery via </strong><strong>Cesarean section</strong>.</li>\r\n</ul>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Phenytoin &amp; Caesarean delivery</strong></p>\r\n<ul>\r\n<li><strong>Phenytoin</strong> is not the first-line drug for controlling seizures in eclampsia. Magnesium sulfate (MgSO4) is preferred due to its efficacy in preventing and controlling eclamptic seizures.</li>\r\n</ul>\r\n<p><strong>b) MgSO4 &amp; expectant management</strong></p>\r\n<ul>\r\n<li>While <strong>MgSO4</strong> is correctly used to control seizures, <strong>expectant management</strong> is not appropriate here. Given the severity of eclampsia and fetal bradycardia, expectant management would increase the risk of adverse maternal and fetal outcomes.</li>\r\n</ul>\r\n<p><strong>c) MgSO4 &amp; Induction of labour </strong></p>\r\n<ul>\r\n<li>Induction of labor can be considered in some cases of eclampsia; however, given that the patient is at <strong>28 weeks gestation</strong>, induction may not be ideal due to the fetal condition (bradycardia) and the immature cervix, making this option less</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY:</strong> Magnesium sulfate is first-line treatment for eclampsia because it prevents the recurrence and decreases the risk of maternal mortality.</p>\r\n<p><strong>Eclampsia is an absolute contraindication to expectant management.</strong></p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Arteriolar spasm</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal detachment</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Macular degeneration</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Purtscher's retinopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23 year primigravida presents to ER with fits. She is diagnosed with eclampsia & MgSO4 was administered. She awakens from her seizure a little while later. In the post-ictal phase, she complains of blurring of vision. What is the most likely finding on retinal examination?</span></p>",
      "unique_key": "DT1289519",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289519,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Arteriolar spasm is the most common retinal finding in eclampsia.</strong> It results from vasospasm caused by severe hypertension, leading to <strong>blurring of vision</strong> or transient visual disturbances, which resolve once blood pressure is controlled.</p>\r\n<p>Option wise explanation :</p>\r\n<p><strong>b) Retinal detachment</strong></p>\r\n<ul>\r\n<li>Retinal detachment is a rare complication in preeclampsia/eclampsia, more commonly associated with severe or untreated cases. It usually presents with more dramatic symptoms like sudden vision loss or \"curtain-like\" vision changes, not just blurring of vision.</li>\r\n</ul>\r\n<p><strong>c) Macular degeneration</strong></p>\r\n<ul>\r\n<li>Macular degeneration is a chronic condition typically related to aging. It is unlikely to be the cause of visual disturbances in a young patient with eclampsia.</li>\r\n</ul>\r\n<p><strong>d) Purtscher's retinopathy</strong></p>\r\n<ul>\r\n<li>Purtscher's retinopathy is a rare finding associated with trauma, acute pancreatitis, or other conditions, and is characterized by retinal hemorrhages and cotton-wool spots. It is not typically seen in eclampsia.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<ul>\r\n<li><strong>The most common findings in patients with severe preeclampsia are an increase in the vein to artery ratio and segmental vasospasm. </strong></li>\r\n<li>Papilloedema in preeclampsia is highly unusual and demands a reevaluation to rule out the possibility of an intracranial tumour or bleeding.</li>\r\n<li>Retinal infarction, termed Purtscher's retinopathy, is rare.</li>\r\n<li>Serous retinal detachment is usually unilateral and seldom causes total visual loss.</li>\r\n</ul>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Preeclampsia</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hypertension</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational hypertension</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hypertension with superimposed preeclampsia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34 year old primigravida presents for her first antenatal visit at 9 weeks of gestation. Her BP is 150/96 mmHg, Repeat BP after 4 hours 150/90 mmHg, No complaints of headache, edema or visual changes. Urine albumin is 1+. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289522",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289522,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Chronic hypertension</strong> is defined as <strong>hypertension present before pregnancy or diagnosed before 20 weeks of gestation</strong>. The patient has high blood pressure and proteinuria at her first antenatal visit at 9 weeks, which suggests that her hypertension was pre-existing, making this the most likely diagnosis.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Preeclampsia</strong></p>\r\n<ul>\r\n<li>Preeclampsia is diagnosed after 20 weeks of gestation with the presence of new-onset hypertension and proteinuria or other signs of organ dysfunction. Since this patient is only at 9 weeks gestation, <strong>preeclampsia</strong> is unlikely.</li>\r\n</ul>\r\n<p><strong>c) Gestational hypertension</strong></p>\r\n<ul>\r\n<li>Gestational hypertension is defined as <strong>new-onset hypertension after 20 weeks of gestation</strong> without proteinuria or signs of end-organ damage. Since this patient is at 9 weeks gestation, this diagnosis is not applicable.</li>\r\n</ul>\r\n<p><strong>d) Chronic hypertension with superimposed preeclampsia</strong></p>\r\n<ul>\r\n<li>Superimposed preeclampsia refers to the development of preeclampsia in a woman with pre-existing chronic hypertension, which typically occurs <strong>after 20 weeks of gestation</strong>. Therefore, this diagnosis is unlikely in the current scenario.</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY-</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120603debd20-c2a0-40b5-a658-14a1f7b30a43.jpg\">",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">An appropriately sized cuff (i.e., length of 1.5 times the circumference of the arm) should be used</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">While taking BP, device should be at heart level of patient</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Korotkoff phase IV should be used to designate diastolic BP</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure should be taken on both arms at the first antenatal visit</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">While taking BP, all of the following precautions should be kept in mind, except:</span></p>",
      "unique_key": "DT1289524",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289524,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Korotkoff phase V</strong> (disappearance of sound) is used to designate <strong>diastolic blood pressure</strong> in pregnancy. <strong>Phase IV</strong> (muffling of sound) was previously used but is not recommended for determining diastolic BP in pregnancy.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) An appropriately sized cuff (i.e., length of 1.5 times the circumference of the arm) should be used</strong></p>\r\n<ul>\r\n<li>Using the correct cuff size is crucial to obtain an accurate BP reading. A cuff that is too small can falsely elevate the BP, and one that is too large can result in falsely low readings.</li>\r\n</ul>\r\n<p><strong>b) While taking BP, the device should be at heart level of the patient</strong></p>\r\n<ul>\r\n<li>The BP measuring device should be at <strong>heart level</strong> to avoid inaccurate readings. If the cuff is placed above or below heart level, the reading may be falsely high or low.</li>\r\n</ul>\r\n<p><strong>d) Blood pressure should be taken on both arms at the first antenatal visit</strong></p>\r\n<ul>\r\n<li>It is a good practice to take blood pressure on <strong>both arms at the first antenatal visit</strong> to detect any significant differences, which could indicate vascular conditions such as coarctation of the aorta.</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY - </strong>Measurement of blood pressure:</p>\r\n<ol>\r\n<li>BP should be measured with the woman in the <strong>sitting position with the arm .</strong></li>\r\n<li><strong>An appropriately sized cuff</strong> (i.e., length of 1.5 times the circumference of the arm) should be used.</li>\r\n<li>While taking BP, <strong>the device should be at the heart level of the patient</strong>.</li>\r\n<li><strong>Korotkoff phase V should be used to designate diastolic BP</strong></li>\r\n<li>BP can be measured using a mercury sphygmomanometer, calibrated aneroid device, or an automated BP device.</li>\r\n</ol>\r\n<p><strong>Reference</strong>: FOGSI GCPR on hypertensive disorders of pregnancy</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal growth restriction</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligohydramnios</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Preterm delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fetal complications associated with preeclampsia are all except:</span></p>",
      "unique_key": "DT1289528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Polyhydramnios</strong> (excess amniotic fluid) is generally <strong>not</strong> associated with preeclampsia. It is more commonly linked to conditions like diabetes or fetal anomalies. Therefore, this option is correct as it does not represent a typical fetal complication of preeclampsia</p>\n<p><strong>a) Fetal growth restriction</strong></p>\n<ul>\n<li><strong>Fetal growth restriction (FGR)</strong> is a common complication associated with preeclampsia. The placental insufficiency resulting from maternal hypertension can lead to inadequate nutrient and oxygen supply to the fetus, causing growth restriction.</li>\n</ul>\n<p><strong>b) Oligohydramnios</strong></p>\n<ul>\n<li><strong>Oligohydramnios</strong>, or reduced amniotic fluid, is often seen in cases of preeclampsia. It can result from decreased renal perfusion in the fetus due to placental insufficiency.</li>\n</ul>\n<p><strong>d) Preterm delivery</strong></p>\n<ul>\n<li><strong>Preterm delivery</strong> is a recognized complication of preeclampsia. Due to the risks associated with severe disease, many cases require early delivery to protect both maternal and fetal health.</li>\n</ul>\n<p><strong>KEY TAKEAWAY- <em>Complications of preeclampsia</em></strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206e36ee84f-de72-43e0-86a1-56d183fe60e6.jpg\">",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Ergometrine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25 year old second gravida, known case of severe preeclampsia, undergoes planned induction at 34 weeks of gestation. After 12 hours of labour, she delivers a female newborn of 2.2 kg. She develops postpartum haemorrhage. All of the following drugs can be used, except?</span></p>",
      "unique_key": "DT1289530",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Ergometrine is contraindicated in severe hypertension and eclampsia</strong>, as there is a risk of severe hypertension associated with its use, which may result in eclampsia or cerebrovascular accident.</p>\r\n<p>Optionwise explanation:</p>\r\n<p><strong>a) Oxytocin</strong></p>\r\n<ul>\r\n<li><strong>Oxytocin</strong> is commonly used for the management of postpartum hemorrhage. It helps to stimulate uterine contractions, promoting uterine tone and reducing bleeding. It is safe to use in patients with preeclampsia.</li>\r\n</ul>\r\n<p><strong>b) Misoprostol</strong></p>\r\n<ul>\r\n<li><strong>Misoprostol</strong> is another medication that can be used effectively for PPH. It is a prostaglandin that helps stimulate uterine contractions and is safe for use in the context of preeclampsia.</li>\r\n</ul>\r\n<p><strong>c) Carboprost</strong></p>\r\n<ul>\r\n<li><strong>Carboprost</strong> (15-methyl PGF2&alpha;) is a prostaglandin used for treating PPH, especially in cases of uterine atony. While it can cause bronchospasm, it can be used with caution in preeclamptic patients, typically after assessing the risk.</li>\r\n</ul>\r\n<p><strong>Key TAKEAWAY - Ergometrine</strong> is contraindicated in patients with hypertension, including those with severe preeclampsia. It can cause vasoconstriction and elevate blood pressure, which can be dangerous in this population.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Icterus gravis neonatorum</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital anemia of the newborn</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrops fetalis</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most serious form of Rh haemolytic disease in the fetus:</span></p>",
      "unique_key": "DT1289532",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289532,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>HYDROPS FETALIS: </strong></p>\r\n<p>This is the <strong>most serious form</strong> of Rh hemolytic disease (HDFN). Excessive destruction of the fetal red cells leads to severe anemia, tissue anoxia and metabolic acidosis.</p>\r\n<p>As a result of fetal anoxemia, there is damage to the liver leading to hypoproteinemia which is responsible for generalized edema (hydrops fetalis), ascites and hydrothorax. Fetal death occurs sooner or later due to cardiac failure.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412064a202cd4-108d-4df9-8f4d-7f033c90b48d.jpg\">\r\n<p>The baby is either stillborn or macerated and even if born alive.</p>\r\n<p><strong>Options:</strong></p>\r\n<p><strong>a)</strong> <strong>Icterus gravis neonatorum</strong><br /> This refers to severe jaundice in the newborn due to excessive bilirubin from hemolysis. While it is a serious condition, it is not the most severe form of Rh disease.</p>\r\n<p><strong>b)</strong> <strong>Congenital anemia of the newborn</strong><br /> This condition involves anemia present at birth but is generally less severe than hydrops fetalis.</p>\r\n<p><strong>d)</strong> <strong>None of the above</strong><br /> This option is incorrect since hydrops fetalis is indeed a serious condition associated with Rh hemolytic disease.</p>\r\n<p><strong>KEY TAKEAWAY : Hydrops fetalis</strong><br /> Hydrops fetalis is the most severe manifestation of Rh hemolytic disease, resulting from significant fetal anemia and heart failure, leading to widespread edema in the fetus.</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle cerebral artery</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Umbilical artery</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic arch</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following fetal arteries is used to assess fetal anemia?</span></p>",
      "unique_key": "DT1289536",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289536,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>MCA PSV &gt;1.5 multiples of the median (MoMs) for corresponding gestational age predicts moderate to severe fetal anemia</strong>. Serial Doppler studies of MCA are the mainstay to assess fetal anemia in red cell alloimmunized pregnancy.</p>\r\n<p><strong>Options:</strong></p>\r\n<p><strong>b)</strong> <strong>Umbilical artery</strong></p>\r\n<p>While the umbilical artery is assessed for fetal well-being and placental function, it is not specifically used to evaluate fetal anemia.</p>\r\n<p><strong>c)</strong> <strong>Aortic arch</strong></p>\r\n<p>The aortic arch is not routinely used for assessing fetal anemia in clinical practice.</p>\r\n<p><strong>d)</strong> <strong>Anterior cerebral artery</strong></p>\r\n<p>Although it can be assessed in fetal brain studies, it is not the primary artery for evaluating fetal anemia.</p>\r\n<p><strong>KEY TAKEAWAY: Middle cerebral artery</strong></p>\r\n<p>The middle cerebral artery is the primary vessel used to evaluate fetal anemia through Doppler ultrasound, with increased blood flow indicating compensatory increased cardiac output in response to anemia.</p>\r\n<p>Uterine artery doppler is used in screening for PIH (PREGNANCY INDUCED HYPERTENSION).</p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Kleihaeur-Betke test</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrazine test</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzidine test</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Guthrie test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Volume of fetal blood entering into the maternal circulation is estimated by:</span></p>",
      "unique_key": "DT1289542",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289542,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A: Approximate</strong> volume of fetal blood entering into the maternal circulation is to be estimated by '<strong>Kleihauer-Betke test'</strong> using acid elution technique to note the number of fetal red cells (dark, refractile bodies) per 50 low power fields.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250118afc722eb-d59f-45af-9d06-912c4f55e23f.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206f179d1d5-8bcc-4782-a88f-949eb10fcb2d.jpg\">\r\n<p><strong>Option b</strong> Nitrazine test measures the pH of vaginal secretions to determine if an expectant mother's amniotic membrane has ruptured. The test involves placing a drop of vaginal fluid on nitrazine paper, which turns blue if the fluid has a pH of greater than 6.0 and is likely amniotic fluid.</p>\r\n<p><strong>Option c</strong> Benzidine test is used to detect occult blood</p>\r\n<p><strong>Option d</strong> Guthrie test also known as the heel prick test, is a blood spot screening test that is routinely performed on newborns to detect genetic disorders like phenylketonuria</p>\r\n<p><strong>Key TAKEAWAY:</strong> <strong>Kleihauer-Betke test is a quantitative test. It estimates the volume of fetomaternal hemorrhage that has occurred to calculate the dose of anti -D.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412064675397a-515c-424c-823e-79e09f86a.jpg\">\r\n<p><strong>Darkly stained cells in this represents fetal cells as they contain HBF which is more resistant to acid than maternal blood which contains HBA .</strong></p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}